Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Chad Thomas Campbell, insider at AngioDynamics
Chad Thomas Campbell Insider Alerts

Get notified the next time Chad Thomas Campbell buys or sells AngioDynamics stock. Enter your email address below to get our daily insider buying and selling report.

Chad Thomas Campbell Insider Information

Senior Vice President and General Manager, Vascular Access, Chad Campbell joined the AngioDynamics team in May 2016 bringing more than 20 years of sales and marketing experience. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien. During his tenure at Covidien, Campbell also held roles as Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell holds a Bachelor of Arts degree from the University of Kentucky.

How do I contact Chad Thomas Campbell?

The corporate mailing address for Mr. Campbell and other AngioDynamics executives is 14 PLAZA DRIVE, LATHAM NY, 12110. AngioDynamics can also be reached via phone at (518) 795-1400 and via email at [email protected]

Has Chad Thomas Campbell been buying or selling shares of AngioDynamics?

Over the course of the past ninety days, Chad Thomas Campbell has sold $291,808.00 in AngioDynamics stock. Most recently, Chad Thomas Campbell sold 10,748 shares of the business's stock in a transaction on Tuesday, October 5th. The shares were sold at an average price of $27.15, for a transaction totalling $291,808.20.

Who are AngioDynamics' active insiders?

AngioDynamics' insider roster includes Chad Campbell (SVP), Scott Centea (VP), and Dave Helsel (SVP).

Are insiders buying or selling shares of AngioDynamics?

During the last twelve months, insiders at the medical instruments supplier sold shares 5 times. They sold a total of 36,242 shares worth more than $928,775.38. The most recent insider tranaction occured on October, 20th when SVP Dave Helsel sold 3,494 shares worth more than $97,727.18. Insiders at AngioDynamics own 4.8 % of the company.

Information on this page was last updated on 10/20/2021.

Chad Thomas Campbell Insider Trading History at AngioDynamics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/5/2021Sell10,748$27.15$291,808.20View SEC Filing Icon  
See Full Table

Chad Thomas Campbell Buying and Selling Activity at AngioDynamics

This chart shows Chad Thomas Campbell's buying and selling at AngioDynamics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AngioDynamics Company Overview

AngioDynamics logo
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Read More

Today's Range

Now: $25.64
Low: $25.41
High: $27.31

50 Day Range

MA: $27.60
Low: $23.36
High: $30.97

2 Week Range

Now: $25.64
Low: $13.72
High: $32.00

Volume

208,768 shs

Average Volume

166,712 shs

Market Capitalization

$990.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!